Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737522) titled 'Myocardial Metabolic Flux in Pulmonary Arterial Hypertension' on July 27.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Imperial College London

Condition: Pulmonary Arterial Hypertension

Intervention: Drug: GLP-1 agonist

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 1, 2026

Target Sample Size: 32

To know more, visit https://clinicaltrials.gov/study/NCT07737522

Disclaimer: Curated by HT Syndication....